| Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
| APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
Mapped by CNV |
|
| RNF144B |
ring finger protein 144B |
Mapped by LD-proxy |
|
| TP53AIP1 |
tumor protein p53 regulated apoptosis inducing protein 1 |
Mapped by significant region |
TAS[11030628]
|
| C11orf82 |
chromosome 11 open reading frame 82 |
Mapped by significant region |
|
| TAX1BP1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
Mapped by significant region |
|
| DFNA5 |
deafness, autosomal dominant 5 |
Mapped by CNV; Mapped by significant region |
|
| GJA1 |
gap junction protein, alpha 1, 43kDa |
Mapped by significant region |
|
| CASP5 |
caspase 5, apoptosis-related cysteine peptidase |
Mapped by significant region |
|
| SPATA4 |
spermatogenesis associated 4 |
Mapped by LD-proxy |
IEP[12019456]
|
| TGFBR1 |
transforming growth factor, beta receptor 1 |
Mapped by significant region |
|
| CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
Mapped by significant region |
|
| MAP1S |
microtubule-associated protein 1S |
Mapped by PBA pathway |
IDA[12762840]
|
| MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
| GZMH |
granzyme H (cathepsin G-like 2, protein h-CCPX) |
Mapped by significant region |
NAS[2402757]
|
| DNAJB13 |
DnaJ (Hsp40) homolog, subfamily B, member 13 |
Mapped by CNV; Mapped by significant region |
IEP[12673577]
|
| GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
Mapped by significant region |
|
| CXCR2 |
chemokine (C-X-C motif) receptor 2 |
Mapped by significant region |
|
| WWOX |
WW domain containing oxidoreductase |
Mapped by significant region |
|
| EGLN3 |
egl nine homolog 3 (C. elegans) |
Mapped by LD-proxy; Mapped by literature SNP |
|
| GATA6 |
GATA binding protein 6 |
Mapped by significant region |
|
| BIRC2 |
baculoviral IAP repeat containing 2 |
Mapped by significant region |
|
| PSMB7 |
proteasome (prosome, macropain) subunit, beta type, 7 |
Mapped by significant region |
|
| ZBTB16 |
zinc finger and BTB domain containing 16 |
Mapped by significant region |
NAS[9294197]
|
| PRKD1 |
protein kinase D1 |
Mapped by significant region |
|
| AATF |
apoptosis antagonizing transcription factor |
Mapped by CNV |
|
| MIEN1 |
migration and invasion enhancer 1 |
Mapped by LD-proxy |
|
| PSMA8 |
proteasome (prosome, macropain) subunit, alpha type, 8 |
Mapped by significant region |
|
| KRT18 |
keratin 18 |
Mapped by PBA pathway |
|
| AATK |
apoptosis-associated tyrosine kinase |
Mapped by LD-proxy |
|
| UBC |
ubiquitin C |
Mapped by CNV |
|
| FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
Mapped by significant region |
|
| SGK1 |
serum/glucocorticoid regulated kinase 1 |
Mapped by significant region |
|
| CADM1 |
cell adhesion molecule 1 |
Mapped by significant region |
|
| BRMS1 |
breast cancer metastasis suppressor 1 |
Mapped by significant region |
|
| GADD45G |
growth arrest and DNA-damage-inducible, gamma |
Mapped by significant region |
|
| PRKCB |
protein kinase C, beta |
Mapped by significant region |
|
| MAPT |
microtubule-associated protein tau |
Mapped by LD-proxy; Mapped by PBA pathway |
|
| AVEN |
apoptosis, caspase activation inhibitor |
Mapped by CNV |
|
| ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
Mapped by significant region |
|
| EI24 |
etoposide induced 2.4 mRNA |
Mapped by significant region |
|
| RNF130 |
ring finger protein 130 |
Mapped by CNV |
|
| ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
Mapped by significant region |
|
| PSMG2 |
proteasome (prosome, macropain) assembly chaperone 2 |
Mapped by CNV |
|
| GREM1 |
gremlin 1 |
Mapped by CNV; Mapped by significant region |
|
| MLL |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) |
Mapped by significant region |
|
| TJP1 |
tight junction protein 1 (zona occludens 1) |
Mapped by CNV; Mapped by significant region |
|
| ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
Mapped by PBA pathway |
|
| BCL7C |
B-cell CLL/lymphoma 7C |
Mapped by CNV |
|
| PSME2 |
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
Mapped by significant region |
|
| RTN3 |
reticulon 3 |
Mapped by significant region |
|
| SHF |
Src homology 2 domain containing F |
Mapped by CNV |
|
| TRAF1 |
TNF receptor-associated factor 1 |
Mapped by significant region |
|
| BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
| RTN4 |
reticulon 4 |
Mapped by CNV |
NAS[11126360]
|
| MCF2L |
MCF.2 cell line derived transforming sequence-like |
Mapped by CNV |
|
| BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
Mapped by CNV |
IDA[18371312]; IPI[7954800]
|
| TMEM219 |
transmembrane protein 219 |
Mapped by CNV |
|
| PSME1 |
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
Mapped by significant region |
|
| UBB |
ubiquitin B |
Mapped by significant region |
|
| ARHGEF4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
Mapped by CNV; Mapped by significant region |
|
| SMNDC1 |
survival motor neuron domain containing 1 |
Mapped by PBA pathway |
|
| DAB2 |
disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
Mapped by significant region |
|
| TAOK2 |
TAO kinase 2 |
Mapped by CNV |
NAS[10660600]
|
| API5 |
apoptosis inhibitor 5 |
Mapped by PBA pathway |
|
| MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
| ADORA2A |
adenosine A2a receptor |
Mapped by CNV |
TAS[7818494]
|
| CASP1 |
caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
Mapped by significant region |
TAS[7876192]
|
| PDCL3 |
phosducin-like 3 |
Mapped by CNV |
|
| POLR2G |
polymerase (RNA) II (DNA directed) polypeptide G |
Mapped by significant region |
|
| DAXX |
death-domain associated protein |
Mapped by LD-proxy; Mapped by PBA pathway |
TAS[15572661]
|
| ARF6 |
ADP-ribosylation factor 6 |
Mapped by PBA pathway |
|
| ERN2 |
endoplasmic reticulum to nucleus signaling 2 |
Mapped by significant region |
|
| PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
Mapped by significant region |
IMP[17599062]
|
| PSMD7 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
Mapped by significant region |
|
| BLID |
BH3-like motif containing, cell death inducer |
Mapped by significant region |
|
| PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
Mapped by CNV |
|
| CARD6 |
caspase recruitment domain family, member 6 |
Mapped by significant region |
|
| DSG3 |
desmoglein 3 |
Mapped by significant region |
|
| C22orf29 |
chromosome 22 open reading frame 29 |
Mapped by CNV |
|
| NEK6 |
NIMA (never in mitosis gene a)-related kinase 6 |
Mapped by significant region |
|
| BIRC6 |
baculoviral IAP repeat containing 6 |
Mapped by CNV |
|
| GSN |
gelsolin |
Mapped by PBA pathway; Mapped by significant region |
|
| PERP |
PERP, TP53 apoptosis effector |
Mapped by significant region |
|
| PDCD10 |
programmed cell death 10 |
Mapped by CNV |
|
| G2E3 |
G2/M-phase specific E3 ubiquitin protein ligase |
Mapped by significant region |
|
| KLF11 |
Kruppel-like factor 11 |
Mapped by significant region |
|
| CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
Mapped by significant region |
IDA[10449408]
|
| DSG2 |
desmoglein 2 |
Mapped by significant region |
IDA[17559062]
|
| SQSTM1 |
sequestosome 1 |
Mapped by CNV |
|
| APC |
adenomatous polyposis coli |
Mapped by LD-proxy; Mapped by PBA pathway |
|
| PSMD5 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
Mapped by significant region |
|
| ATG5 |
ATG5 autophagy related 5 homolog (S. cerevisiae) |
Mapped by CNV |
|
| MAPK7 |
mitogen-activated protein kinase 7 |
Mapped by significant region |
|
| PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
Mapped by significant region |
|
| OPA1 |
optic atrophy 1 (autosomal dominant) |
Mapped by CNV |
|
| PDCD7 |
programmed cell death 7 |
Mapped by PBA pathway |
|
| DSG1 |
desmoglein 1 |
Mapped by significant region |
|
| BIRC3 |
baculoviral IAP repeat containing 3 |
Mapped by significant region |
|
| CYCS |
cytochrome c, somatic |
Mapped by CNV; Mapped by significant region |
IDA[8689682]
|
| FADD |
Fas (TNFRSF6)-associated via death domain |
Mapped by significant region |
|
| PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
Mapped by LD-proxy |
NAS[12054647]
|